Alex Tung Memorial Innovative Research Award for Embryonal Rhabdomyosarcoma Studies
This Innovative Research Award supports research on rhabdomyosarcoma, an aggressive and highly malignant form of cancer that develops from skeletal muscle cells that have failed to fully differentiate. It occurs mostly in children under age 18. The application process and guidelines will be the same as with the general IRA (see above) except that the applicant must document how the project specifically targets rhabdomyosarcoma or other related sarcomas. Funding will be up to $25,000. This award is funded through the generosity of Sarah Young, whose son Alex Tung died of rhabdomyosarcoma when he was 31 years old. Read more about Alex and Sarah here.
The annual application deadline is October 1.
NOTE TO APPLICANTS: We have changed to PieStar. You will need to create an account to log in. But this will allow you to save your information as you are working on it!